Short answer
Every material launch assumption has a burn rate attached to it. When one moves, the cost arrives as time: payroll, inventory, and site support spent waiting. Price each assumption's delay before it slips, and decide in advance what changes when it does.
The Meduloc record
On August 6, 2026, Meduloc announced the closing of a $4 million Series B financing led by GenHenn Capital, with participation from Life Sciences Greenhouse Investments, Ben Franklin Technology Partners of Southeastern Pennsylvania, Broad Street Angels, and others. Meduloc, based in West Chester, Pennsylvania, is commercializing a flexible nitinol intramedullary fracture fixation system: sterile, single-use, cleared by the FDA in November 2025, and designed for a range of upper- and lower-extremity long-bone fracture applications in adult and pediatric patients.
The announcement is specific about what the money is for. The financing will support “Meduloc’s controlled alpha launch, continued generation of clinical evidence and development of the commercial infrastructure required to bring its fracture fixation platform to a broader range of surgeons and patients.” President and CEO Sarah Sachinis said the capital enables the company “to begin our alpha launch, build meaningful clinical experience and establish the foundation for broader adoption across adult and pediatric fracture care.”
Read that as a financing plan. The round is not sized against a revenue forecast. It is sized against a set of things the company needs to learn and build: a controlled launch with chosen sites, a clinical evidence base, and the commercial infrastructure to expand afterward. Each of those lines is a bundle of assumptions with dates attached: how long sites take to activate, how quickly cases accumulate, what the evidence must show before the next group of users is added.
That is the right shape for a launch raise. It also invites a harder question. Every assumption inside the plan carries a cost if it moves. How much runway does each one buy, and how much does it burn when it slips?
Runway is a stack of dated assumptions
A financing model produces a single number: months of runway. The number reads as a property of the company. It is actually a property of the assumptions underneath.
Suppose the model says eighteen months. Inside it: sites activate within 90 days of contract, payment clearance arrives by the second quarter, a trained rep reaches full productivity in two quarters, inventory turns on a six-week cycle, the first ten accounts reorder within 60 days of first case. Each of those is a dated bet. The eighteen months exists only while the bets hold.
This is why two companies with the same cash and the same burn can have completely different runway. One has assumptions with recent evidence and early warning. The other has assumptions nobody has checked since the model was built. The bank balance cannot tell them apart. The register can.
Price the delay, not the plan
The useful question is not “what does the launch cost.” It is “what does a month of delay cost, per assumption.”
The arithmetic is simple. A company burning $300,000 a month gross loses $300,000 of runway for every month a gating assumption slips. But the full price is rarely just burn. A 90-day slip in site activation can mean a production lot approaching expiry, reps carrying a territory with nothing to sell into it, a trained site team going cold, and a forecast that moves a quarter and takes board credibility with it. Some of those costs are cash. Some are momentum, which converts back into cash later at a bad rate.
A worked example, composite and not a customer case. Halcyon Medical burns $280,000 a month. Its launch plan assumes procurement sign-off in under 90 days. Site evidence now says 120. Three of its five first sites are affected.
| Assumption under pressure | Linked spend | Monthly cost of delay | First place it shows |
|---|---|---|---|
| Procurement sign-off in 90 days | 3 field reps, site support | $84,000 in idle territory cost | Forecast moves a quarter |
| First case to reorder in 60 days | 2 production lots on consignment | $35,000 in working capital, plus expiry risk | Lot 2 write-down |
| Reps productive in 2 quarters | 9 hires planned for Q1 | $120,000 per quarter of premature payroll | Hiring plan vs. pipeline |
None of these numbers is exotic. The discipline is attaching them to the assumption while the assumption is still alive, so the slip arrives with a price tag instead of a post-mortem.
Decide the lever before the slip
When Halcyon’s procurement assumption moved from 90 to 120 days, three levers were available. Hold the Q1 hiring plan and accept three months of partially idle payroll. Narrow the launch to the two sites whose procurement path is proven, and cut the support spend around the other three. Or raise a bridge, and pay for the same learning with dilution instead of budget.
There is no universally right answer. There is a wrong time to have the conversation: after the milestone is missed, when the options have already started spending themselves. The point of pricing the assumption in advance is that the lever decision can happen when the evidence moves, not when the cash does. The rule to write down: when this assumption slips past its trigger, we pull this lever, and this person approves it.
The model is a map, not a forecast
Investors ask for the model, and the model has to be defensible. But the operating value of the model is not prediction. It is the list of things that would have to be true.
Keep two artifacts side by side. The financing model, which answers to the board. And the assumption register, which answers to the launch: each material assumption with an owner, an evidence date, a confidence level, the spend it controls, and the cost per month of being wrong. When the register updates, the model follows. When the two drift apart, the runway number in the board deck is describing a company that no longer exists.
Meduloc’s announcement describes the intended direction: controlled launch, evidence, infrastructure. The release does not disclose the company’s burn or its internal assumptions, and it does not need to. The discipline matters more at $4 million than at $40 million. At that scale, one slipped gating assumption is not a variance. It is a financing event.
When spending ahead of evidence is the right call
Pricing assumptions does not mean refusing to spend until every one of them is proven. Some spend has to run ahead of evidence or the evidence never arrives. Inventory must exist before the first case. Reps must be trained before the first site activates. Part 4 of this series covered hiring against a payment event with a statutory expiry date: there is no safe default, only a recorded decision tied to the event, with a trigger that reopens the plan if the event moves.
The distinction is between spending ahead of evidence deliberately, with the bet written down and priced, and spending ahead of evidence by default because the plan said so in June.
What this does not prove
Meduloc’s release says what the financing is for. It does not disclose burn, allocation across the three stated purposes, or the company’s internal assumptions, and nothing here claims to know them. The Halcyon Medical numbers are a composite illustration, not a benchmark for what a launch should cost.
The delay-pricing arithmetic also cuts both ways. Narrowing a launch to save burn can starve the evidence generation the next financing depends on. A cheap month that costs a site relationship or a dataset can be the most expensive month in the plan. Pricing assumptions makes these tradeoffs visible. It does not make them easy.
Sources
- Meduloc, “Meduloc Closes $4 Million Series B Financing Led by GenHenn Capital,” PR Newswire, August 6, 2026
- Orthopedics This Week, “Meduloc Raises $4 Million in Series B,” August 2026
- RevWorx Insights, “One Reimbursement Change, Seven Commercial Decisions” — hiring against a payment clock — /insights/one-reimbursement-change
Frequently asked questions
- Our burn is not steady month to month. Does the pricing still work?
- Use a range, and attach it to the specific spend the assumption controls rather than to total burn. Idle territory cost, consigned inventory, premature payroll: those are line items with their own arithmetic, and they are more honest than a blended burn rate.
- Who should own this, finance or the launch lead?
- Both, with different artifacts. Finance owns the model. The launch lead owns the register. The monthly review is where the two are reconciled, and the reconciliation is the point.
- How many assumptions should be priced?
- The five to eight whose slip would change a spending decision. Pricing everything is bookkeeping. Pricing nothing is what most teams already have.
- What if the slip is good news, like slower procurement because the account turned out bigger than planned?
- Price it the same way. Favorable surprises consume runway too, through inventory, staffing, and timing. The register records what changed and what it costs. Whether the change is welcome is a separate question.